These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 3011994)

  • 1. Effect of chronic desipramine treatment on dihydroalprenolol, imipramine, and desipramine binding sites: a quantitative autoradiographic study in the rat brain.
    Biegon A
    J Neurochem; 1986 Jul; 47(1):77-80. PubMed ID: 3011994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Down regulation of dihydroalprenolol and imipramine binding sites in brain of rats repeatedly treated with imipramine.
    Kinnier WJ; Chuang DM; Costa E
    Eur J Pharmacol; 1980 Oct; 67(2-3):289-94. PubMed ID: 6257531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of age on the rate of recovery of beta-adrenergic receptors in rat brain following desmethylimipramine-induced subsensitivity.
    Greenberg LH; Brunswick DJ; Weiss B
    Brain Res; 1985 Feb; 328(1):81-8. PubMed ID: 2982468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic desmethylimipramine or electroconvulsive shock on selected brain and platelet neurotransmitter recognition sites.
    Abel MS; Clody DE; Wennogle LP; Meyerson LR
    Biochem Pharmacol; 1985 Mar; 34(5):679-83. PubMed ID: 2983735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reevaluation of the regulation of beta-adrenergic receptor binding by desipramine treatment.
    Riva MA; Creese I
    Mol Pharmacol; 1989 Jul; 36(1):211-8. PubMed ID: 2546051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid-eye-movement sleep deprivation decreases the density of 3H-dihydroalprenolol and 3H-imipramine binding sites in the rat cerebral cortex.
    Mogilnicka E; Arbilla S; Depoortere H; Langer SZ
    Eur J Pharmacol; 1980 Jul; 65(2-3):289-92. PubMed ID: 7398791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic and serotonergic receptor binding in rat brain after chronic desmethylimipramine treatment.
    Bergstrom DA; Kellar KJ
    J Pharmacol Exp Ther; 1979 May; 209(2):256-61. PubMed ID: 220405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The distribution of imipramine and desipramine in rat brain regions after single and chronic administration of imipramine.
    Szymura-Oleksiak J; Panas M; ChruĊ›ciel W
    Pol J Pharmacol Pharm; 1984; 36(1):21-6. PubMed ID: 6462958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoradiographic analysis of the in vivo distribution of 3H-imipramine and 3H-desipramine in brain: comparison to in vitro binding patterns.
    Duncan GE; Paul IA; Fassberg JB; Powell KR; Stumpf WE; Breese GR
    Pharmacol Biochem Behav; 1991 Mar; 38(3):621-31. PubMed ID: 2068199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic dosage of imipramine in animal experiment: concentrations of imipramine and desipramine in the rat brain after various modes of dosage.
    Melzacka M; Rurak A; Danek L; Daniel W; Vetulani J
    Pol J Pharmacol Pharm; 1985; 37(4):525-32. PubMed ID: 4080646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of REM sleep deprivation and desipramine on beta-adrenergic binding sites in rat brain.
    Radulovacki M; Micovic N
    Brain Res; 1982 Mar; 235(2):393-6. PubMed ID: 6329418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of imipramine treatment on brain serotonin receptors and beta-adrenoceptors and on pineal beta-adrenergic function in adult and aged rats.
    Friedman E; Cooper T; Yocca F
    Eur J Pharmacol; 1986 Apr; 123(3):351-6. PubMed ID: 3013651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and characterization of [3H]desmethylimipramine binding sites in rat brain by quantitative autoradiography.
    Biegon A; Rainbow TC
    J Neurosci; 1983 May; 3(5):1069-76. PubMed ID: 6302234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine administration in the olfactory bulbectomized rat: changes in brain beta-adrenoceptor and 5-HT2A binding sites and their relationship to behaviour.
    Mudunkotuwa NT; Horton RW
    Br J Pharmacol; 1996 Apr; 117(7):1481-6. PubMed ID: 8730743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional distribution of imipramine, desipramine and specific [3H]desipramine binding sites in the rat brain after acute and chronic treatment with imipramine.
    Daniel W; Danek L; Janczar L; Nocon H; Melzacka M
    J Pharm Pharmacol; 1991 Jan; 43(1):31-5. PubMed ID: 1676056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroanatomically selective down-regulation of beta adrenergic receptors by chronic imipramine treatment: relationships to the topography of [3H]imipramine and [3H] desipramine binding sites.
    Duncan GE; Paul IA; Powell KR; Fassberg JB; Stumpf WE; Breese GR
    J Pharmacol Exp Ther; 1989 Jan; 248(1):470-7. PubMed ID: 2536433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral pharmacokinetics of imipramine in rats after single and multiple dosages.
    Daniel W; Adamus A; Melzacka M; Szymura J; Vetulani J
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Nov; 317(3):209-13. PubMed ID: 7322212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoradiographic demonstration of binding sites for [3H]desipramine in rat brain.
    Slater P; Crossman AR; Sambrook MA
    Neurosci Lett; 1982 Aug; 31(3):259-63. PubMed ID: 7133561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic antidepressant treatment and mouse brain 3H-imipramine binding.
    Severson JA; Anderson B
    J Neurosci Res; 1986; 16(2):429-38. PubMed ID: 3020258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative autoradiography of central beta adrenoceptor subtypes: comparison of the effects of chronic treatment with desipramine or centrally administered l-isoproterenol.
    Ordway GA; Gambarana C; Frazer A
    J Pharmacol Exp Ther; 1988 Oct; 247(1):379-89. PubMed ID: 2845059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.